Petru Fabian Lungu

Mr. Petru Fabian Lungu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ASAlexandra Savuca
Alexandra Savuca
ACAlexandrina Curpan
Alexandrina Curpan
LHLuminita Diana Hritcu
Luminita Diana Hritcu
PPProca Teodora Teodora Proca
Proca Teodora Teodora Proca
Ioana - Miruna BalmusIoana - Miruna Balmus
Ioana - Miruna Balmus
CSCarmen Solcan
Carmen Solcan
The effects of exposure to environmental pollutants on neurological processes are of increasing concern due to their potential to induce oxidative stress and neurotoxicity. Considering that many industries are currently using different types of plastics as raw materials, packaging, or distribution pipes, microplastics (MPs) have become one of the biggest threats to the environment and human health. These consequences have led to the need to raise the awareness regarding MPs negative neurological effects and implication in neuropsychiatric pathologies, such as schizophrenia. The study aims to use three zebrafish models of schizophrenia obtained by exposure to ketamine (Ket), methionine (Met), and their combination to investigate the effects of MP exposure on various nervous system structures and the possible interactions with oxidative stress. The results showed that MPs can interact with ketamine and methionine, increasing the severity and frequency of optic tectum lesions, while co-exposure (MP+Met+Ket) resulted in attenuated effects. Regarding oxidative status, we found that all exposure formulations led to oxidative stress, changes in antioxidant defense mechanisms, or compensatory responses to oxidative damage. Met exposure induced structural changes such as necrosis and edema, while paradoxically activating periventricular cell proliferation. Taken together, these findings highlight the complex interplay between environmental pollutants and neurotoxicants in modulating neurotoxicity.

3 April 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
PLPetru Fabian Lungu
Petru Fabian Lungu
CLCorina-Miruna Lungu
Corina-Miruna Lungu
Alin Stelian CiobicăAlin Stelian Ciobică
Alin Stelian Ciobică
Ioana - Miruna BalmusIoana - Miruna Balmus
Ioana - Miruna Balmus
RVRaluca Vitalaru
Raluca Vitalaru
IGIrina Gurzu
Irina Gurzu
The majority of schizophrenia-affected individuals display deficiencies in multiple cognitive domains such as attention, working memory, long-term memory, and learning, deficiencies that are stable throughout the disease. The purpose of this narrative review was to examine the effect of antipsychotics on several cognitive domains affected by schizophrenia. Methods: We searched MEDLINE, Elsevier, Scopus, and DOAJ databases for randomized controlled trials and other studies investigating the effects of typical and atypical antipsychotics on cognition in patients with schizophrenia in studies conducted in the last decade. Results: The majority of studies included in this review showed that antipsychotics (especially SGAs) have positive effects on both cognition and general psychopathology of schizophrenia. We mention that treatment with antipsychotic substances represents an ongoing effort of the researchers, who are constantly searching for the best approach to meet the mental health needs of schizophrenia patients. Conclusions: Even with those positive results, it should be noted that more studies are needed in order to fully observe the various effects of certain antipsychotic substances on cognition.

28 June 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
PLPetru Fabian Lungu
Petru Fabian Lungu
CLCorina-Miruna Lungu
Corina-Miruna Lungu
Alin Stelian CiobicăAlin Stelian Ciobică
Alin Stelian Ciobică
Ioana - Miruna BalmusIoana - Miruna Balmus
Ioana - Miruna Balmus
ABAlexandra Bolos
Alexandra Bolos
ALAlina Costina Luca
Alina Costina Luca
Metacognition essentially represents “thinking about thinking”, or the individual’s capacity to control and monitor their own cognitive processes. Metacognition impairment in schizophrenia represents a core feature of the disease, and, in the last fifteen years, the subject has evolved into a growing study area concentrating on a wide variety of processes, such as clinical insight, autobiographical memory, cognitive beliefs, reasoning, and memory biases. Since metacognition is a complex subject, we wanted to focus on the different nuances of metacognition transposed into the lives of patients diagnosed with either schizophrenia or a schizoaffective disorder. Therefore, this narrative review aims to analyze the literature in order to provide an insight regarding the current methods and approaches in the study of metacognition in schizophrenia or schizoaffective disorders, as well as the results provided. Results from the reviewed studies showed that patients with schizophrenia have a lower metacognitive ability, which is strongly reflected in their lives. Studies to date have highlighted the interaction between schizophrenia symptoms and metacognition, which shows how metacognition impacts work performance, autobiographical memory, motivation, the severity of symptoms, and social cognition.

14 October 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PLPetru Fabian Lungu
Petru Fabian Lungu
LHLuminita Diana Hritcu
Luminita Diana Hritcu
MNMircea Nicusor Nicoara
Mircea Nicusor Nicoara
ASAlexandra Savuca
Alexandra Savuca
ACAlexandrina Curpan
Alexandrina Curpan
Gabriel-Ionut Ionut PlavanGabriel-Ionut Ionut Plavan
Gabriel-Ionut Ionut Plavan
Background: Schizophrenia (SCZ) is a psychiatric disorder that negatively impacts patients’ quality of life, frequently inducing difficulties in managing day-to-day tasks. Current research is persistently working on finding therapeutic methods to alleviate the positive and negative symptoms, as well as the associated cognitive dysfunctions. Since the main therapeutic approach in SCZ is antipsychotics, the current study aimed to explore the effects of typical (haloperidol, HAL) vs. atypical (risperidone, RIS) antipsychotics on the cognitive functions in an animal model (Danio rerio) of SCZ, obtained by ketamine (KET) administration. Methods: The cognitive evaluation of the zebrafish was performed using memory and learning tests based on two stimuli: food and colours (i.e., T memory test and novel object recognition (NOR) test, respectively). Results: According to the behavioural analyses, HAL significantly enhanced the cognitive performances of the SCZ model, as compared to RIS. Nonetheless, HAL and RIS exhibited comparable effects on social behaviour in the SCZ model. Interestingly, both HAL and RIS enhanced the interest for the novel object in the NOR test in control individuals, but significantly decreased it in the SCZ model. The interaction between KET and RIS could exhibit sedative properties. Conclusions: Both typical (HAL) and atypical (RIS) antipsychotics alleviated cognitive, socio-affective, and decision-making impairments in a ketamine-based adult zebrafish model of schizophrenia. HAL was more effective, particularly in food-stimulated decision-making compared to novel object or social stimuli. Colour influenced behavioural responses, with silver linked to prey/feeding effects and red perceived as aversive. The KET–RIS combination induced exploratory impairments, possibly due to sedative effects. These findings highlight differential pharmacological and ethological modulation of schizophrenia-like behaviours.

12 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
CICătălina Ionescu
Cătălina Ionescu
PLPetru Fabian Lungu
Petru Fabian Lungu
VRViorica Rarinca
Viorica Rarinca
MVMalina Visternicu
Malina Visternicu
MNMircea Nicusor Nicoara
Mircea Nicusor Nicoara
Alin Stelian CiobicăAlin Stelian Ciobică
Alin Stelian Ciobică
Caffeine, one of the most widely consumed psychoactive substances, is known to modulate central nervous system activity, but its developmental and neurotoxic effects remain insufficiently understood. The zebrafish (Danio rerio), a valuable vertebrate model for toxicological and neurobehavioral research, provides an efficient system to evaluate the impact of caffeine exposure during early development. This review investigates the dose-dependent effects of caffeine on zebrafish larvae, focusing on neurobehavioral alterations, oxidative stress markers, and developmental outcomes. Behavioral assays revealed significant changes in locomotor activity, anxiety-like responses, memory performance, and sleep patterns, suggesting alterations in neural circuitry and associated cognitive and physiological processes, suggesting altered neural circuitry. Biochemical analyses indicated increased levels of reactive oxygen species (ROS), lipid peroxidation, and modulation of antioxidant defense enzymes, highlighting oxidative stress as a potential mechanism underlying caffeine-induced toxicity. Furthermore, embryonic exposure was associated with developmental anomalies, including delayed hatching and morphological deformities at higher concentrations. Collectively, this review article highlights that caffeine exposure can disrupt neurobehavioral function, induce oxidative imbalance, and impair normal development in zebrafish, supporting its use as a model for assessing the neurotoxicological risks of psychoactive substances.

23 February 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
OOOana-Georgiana Oprea
Oana-Georgiana Oprea
PLPetru Fabian Lungu
Petru Fabian Lungu
ICIonut-Alexandru Chelaru
Ionut-Alexandru Chelaru
Ioana - Miruna BalmusIoana - Miruna Balmus
Ioana - Miruna Balmus
Roxana Strungaru-JijieRoxana Strungaru-Jijie
Roxana Strungaru-Jijie
SCStefan Chiriac
Stefan Chiriac
Background/Objectives: Aggressive behaviour is commonly associated with neurodevelopmental disorders, such as autism spectrum disorder (ASD), and could be understood as a response to daily stress routines, which negatively impacts patients’ quality of life. Oxytocin (OT), a neuropeptide involved in social bonding and socio-affective regulation, has emerged as a promising candidate to enrich, rather than replace, current pharmacological approaches in managing ASD-associated aggressive behaviour. In this study, we examined the potential of OT to modulate aggressive behaviour frequency in a VPA-based animal model of ASD. Methods: Sixty adult zebrafish (1:1 sex ratio) were divided into six groups (n = 10/group) and received the following treatment for 7 consecutive days: CTR—control (no treatment); VPA (28.8 mg/L valproic acid); OT (33.2 ng/mL oxytocin); RIS (170 μg/L risperidone); VPA + OT (28.8 mg/L valproic acid and 33.2 ng/mL oxytocin); and VPA + RIS (28.8 mg/L valproic acid and 170 μg/L risperidone). The locomotor performance, and socio-affective and aggressive behaviours, were measured in the Novel Tank and Mirror Biting tests at the end of the treatments. Results: We observed that the VPA treatment led to locomotion and socio-affective impairments, as well as aggressive behaviour. Also, we found that OT and RIS had comparable potential to modulate the frequency of aggressive and anxiety-like behaviours. Conclusions: Our preliminary data showed that OT has the potential to modulate the frequency of anxiety-like and aggressive behaviours, similarly to the atypical antipsychotic, RIS, in our VPA zebrafish model. However, further studies are needed to investigate the mechanisms of action and their potential synergistic effects.